InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.08
(
0.07%
)
Bitcoin
63,083.73
(
-0.13%
)
Post# of 252311
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: DewDiligence post# 245900

Tuesday, 03/14/2023 4:18:07 PM

Tuesday, March 14, 2023 4:18:07 PM

Post# of 252311

COVID antiviral, Pomotrelvir



I don't think that any company focused on COVID antivirals is a good investment. For any of them to be effective they have to be taken soon after symptoms begin and then you only get at most a few weeks of use. Plus they can't charge enough for the drug to make it profitable.

Given our current healthcare system the chance that you are going to be able to get a COVID antiviral in time for it to make a difference is close to nil for most people.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up